RE: Thoughts on potential buy-out20 May 2024 09:30
Researcher 1, re yours of 17th May
I have no agenda, paranoia not helpful here. If a blood sample is spiked with a malignant cell, Parsortix will capture it, a doddle akin to shooting animals in a zoo. but as I and others have repeatedly pointed out, from a population of patients with metastatic malignancy, it is not possible to capture malignant cells from a single blood sample on 100% of patients; some will simply not have circulating tumour cells to capture at the time of sampling.
No agenda, just fact.